Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BERLIN, March 29, 2012 (GLOBE NEWSWIRE) -- aap Implantate AG (Frankfurt:AAQ), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market,...
-
SAN DIEGO and COLUMBUS, Ohio, March 29, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous...
-
MENLO PARK, Calif., March 28, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received the remaining license fee payment resulting from its collaboration with...
-
CARLSBAD, Calif., March 26, 2012 (GLOBE NEWSWIRE) -- As exciting as boxing is, it just has not been the same since "Iron" Mike Tyson left the ring. When he fought it was truly an event much like...
-
NEWARK, Calif., March 20, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) and genOway (NYSE:ALGEN) announced today that they have entered into a license agreement under which StemCells has...
-
LONDON, March 20, 2012 (GLOBE NEWSWIRE) -- IP&TV World Forum -- Sagemcom, a leading provider of set-top boxes in Europe, and Rovi Corporation (Nasdaq:ROVI) today announced that the Sagemcom...
-
NEW YORK, March 14, 2012 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (OTCQB:XELB) has signed an exclusive licensing agreement with Cosmoda Corporation. This agreement will give Cosmoda the license to...
-
NEW YORK, March 14, 2012 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (OTCQB:XELB) has signed an exclusive licensing agreement with Huhtamaki, Inc. This agreement will give Huhtamaki the license to...
-
Agenus to Receive $9 Million Upfront Agenus to Host a Conference Call at 11 am ET Today LEXINGTON, Mass., March 5, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) announced today that...
-
NEW YORK, March 2, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. - announced today an agreement with two LFB Group companies, LFB Biotechnologies S.A.S and GTC Biotherapeutics, Inc., to license the...